COVID-19

Rondi Kauffmann, MD, MPH, seated, reviews a patient’s medical history with Vanderbilt University School of Medicine students Natasha Hughes, far left, and Candace Grisham, during a recent surgical clinic.

Pandemic spurs expansion of surgical care for underserved

When the COVID-19 pandemic shut down international travel necessary for overseas medical initiatives, Vanderbilt’s Rondi Kauffmann, MD, MPH, began brainstorming ways to extend surgical care to those in need much closer to home.

Boosta-Palooza

VUMC employees were able to receive a single booster dose of the Pfizer COVID-19 vaccine at this week’s Boosta-Palooza event.

Pediatricians seeing increase in children with MIS-C after latest COVID surge

AstraZeneca seeks emergency approval for COVID-19 antibodies isolated at VUMC

Biopharmaceutical company AstraZeneca has requested emergency use authorization (EUA) from the U.S. Food and Drug Administration for a long-acting antibody combination originally developed at Vanderbilt University Medical Center to protect against COVID-19.

VUMC research contributed to first COVID-19 pill now under review

Vanderbilt research helped allow pharmaceutical giant Merck & Co. to authorization for the first oral antiviral pill to treat COVID-19.

The COVID Mass Vaccination Site Team faced a daunting task – put 200,000 shots in arms in six months. The team never wavered.

The accomplishment earned the group the Elevate Team Award.

1 9 10 11 12 13 40